Diethylcarbamazine: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
Ostermayer (talk | contribs) |
||
| Line 1: | Line 1: | ||
==Overview== | ==Overview== | ||
Diethylcarbamazine (DEC) used globally its anti-filaricidal activity<ref>Peixoto CA et al. Anti-inflammatory effects of diethylcarbamazine: A review. European Journal of Pharmacology 734 (2014) 35–41</ref> | Diethylcarbamazine (DEC) used globally its anti-filaricidal activity<ref>Peixoto CA et al. Anti-inflammatory effects of diethylcarbamazine: A review. European Journal of Pharmacology 734 (2014) 35–41</ref> | ||
==Administration== | ==Administration== | ||
*Mechanism of Action: interferes with cyclooxygenase and lipoxygenase pathways, reducing the production of thromboxane, prostacyclin, prostaglandin and leukotrienes | *Mechanism of Action: interferes with cyclooxygenase and lipoxygenase pathways, reducing the production of thromboxane, prostacyclin, prostaglandin and leukotrienes | ||
Revision as of 12:51, 3 April 2022
Overview
Diethylcarbamazine (DEC) used globally its anti-filaricidal activity[1]
Administration
- Mechanism of Action: interferes with cyclooxygenase and lipoxygenase pathways, reducing the production of thromboxane, prostacyclin, prostaglandin and leukotrienes
- Dosage Forms:
- Routes of Administration:
- Common Trade Names:
Adult Dosing
Pediatric Dosing
Special Populations
Pregnancy Rating
Lactation risk
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
Mechanism of Action
Comments
See Also
References
- ↑ Peixoto CA et al. Anti-inflammatory effects of diethylcarbamazine: A review. European Journal of Pharmacology 734 (2014) 35–41